Johnson Investment Counsel Inc Edwards Lifesciences Corp Transaction History

Johnson Investment Counsel Inc

$9.44 Billion
Q2 2024

A detailed history of Johnson Investment Counsel Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Johnson Investment Counsel Inc holds 9,095 shares of EW stock, worth $595,540. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,095

Previous 9,170 0.82%

Holding current value

$595,540

Previous $876,000 4.11%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$84.3 - $94.31 $6,322 - $7,073	-75 Reduced 0.82%	9,095 $840,000
Q1 2024 May 09, 2024	BUY	$72.54 - $95.56 $20,891 - $27,521	288 Added 3.24%	9,170 $876,000
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $75,861 - $102,251	-1,095 Reduced 10.98%	8,882 $615,000
Q2 2023 Aug 10, 2023	BUY	$81.41 - $94.33 $109,496 - $126,873	1,345 Added 15.58%	9,977 $941,000
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $1,633 - $1,859	-22 Reduced 0.25%	8,632 $714,000
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $17,075 - $21,860	-250 Reduced 2.81%	8,654 $645,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $15,567 - $20,277	189 Added 2.17%	8,904 $736,000
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $5,276 - $7,824	61 Added 0.7%	8,715 $829,000
Q1 2022 May 11, 2022	SELL	$101.96 - $128.34 $5,403 - $6,802	-53 Reduced 0.61%	8,654 $1.02 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $514 - $613	5 Added 0.06%	8,707 $986,000
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $15,678 - $19,590	-187 Reduced 2.1%	8,702 $901,000
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $1,967 - $2,266	-25 Reduced 0.28%	8,889 $743,000
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $11,972 - $15,235	-167 Reduced 1.84%	8,914 $813,000
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $339,658 - $454,235	5,903 Added 185.75%	9,081 $628,000
Q1 2020 May 20, 2020	SELL	$52.41 - $81.0 $11,425 - $17,658	-218 Reduced 6.42%	3,178 $599,000
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $1,075 - $1,231	15 Added 0.44%	3,396 $792,000
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $18,341 - $22,478	298 Added 9.67%	3,381 $744,000
Q1 2019 May 13, 2019	BUY	$47.89 - $64.05 $383 - $512	8 Added 0.26%	3,083 $589,000
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $10,210 - $12,526	-220 Reduced 6.68%	3,075 $470,000
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $8,500 - $10,793	186 Added 5.98%	3,295 $573,000
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $12,650 - $15,287	-298 Reduced 8.75%	3,109 $452,000
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $9,074 - $11,577	-244 Reduced 6.68%	3,407 $475,000
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $88,360 - $103,004	-2,615 Reduced 41.73%	3,651 $411,000
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $227,393 - $243,308	6,266	6,266 $684,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.

Account

Johnson Investment Counsel Inc Edwards Lifesciences Corp Transaction History